期刊文献+

大鼠血清淀粉样物质P(SAP)基因的克隆及重组腺病毒制备 被引量:1

Cloning of rat serum amyloid P component gene and preparation of its recombinant adenovirus vector
下载PDF
导出
摘要 目的:制备能够表达大鼠血清淀粉样物质P(Serum amyloid P component,SAP)的重组腺病毒。方法:采用RT-PCR扩增的方法获取大鼠SAP,并将该基因采用定向克隆的方法克隆进入穿梭质粒pAdTrace-TO4中,进一步采用同源重组的方法将该质粒和腺病毒骨架质粒Adeasy-1在大肠杆菌BJ5183中同源重组,然后用脂质体介导的方法导入包装细胞HEK293中,产生表达目的基因的重组腺病毒,扩增病毒后用倍比稀释法测定其滴度。结果:通过PCR技术从重组穿梭质粒和重组腺病毒质粒中扩增出700bp左右插入片段,测序结果和基因库中的基因序列一致。扩增后的重组腺病毒滴度为2.8×108pfu/ml。结论:成功构建了携带SAP基因的重组腺病毒载体Adeasy-1-SAP,为探讨SAP对肺纤维化的作用及其机制打下基础。 Objective:To construct the recombinant adenovirus vector carrying rat serum amyloid P component(SAP)as preparation for later use.Methods:Rat SAP was obtained by using RT-PCR amplification and then cloned into the shutter plasmid pAdTrace-TO4.Subsequently,this newly constructed plasmid pAdTrace-TO4-SAP was followed by homologous recombination with bone plasmid pAdEasy-1 in BJ5183.Recombinant adenovirus was obtained after being packaged in human embryonic kidney cells HEK293 by lipofectAmineTM2000 mediation.After amplification the recombined adenovirus,we determined its titer by end-point dilution assay.Results:In recombinant shuttle plasmid and recombinant adenovirus,a fragment of 700 bp detected by PCR was identical with that included in Genbank.The titer of recombinant adenovirus reached 2.8×10^8 pfu/ml.Conclusion:The recombinant adenovirus containing SAP gene was constructed successfully.This will provides a good basis for further study about the influence of SAP on lung fibrosis.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第4期579-581,共3页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(30700915)
关键词 血清淀粉样物质P 腺病毒 肺纤维化 分子克隆 SAP Adenovirus Lungfibrosis Clone
  • 相关文献

参考文献9

  • 1Steel D M,Whitehead A S.The major acute phase reactants:C-re-active protein,serum amyloid P component and serum amyloid A protein[J].Immunol Today,1994,15(2):81-88.
  • 2Mold C,Gresham H D,Du Clos T W.Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs[J].J Immunol,2001,166(2):1200-1205.
  • 3Armstrong GD,Mulvey GL,Marcato P,et al.Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs[J].J Infect Dis,2006,193(8):1120-1124.
  • 4Pilling D,Buckley CD,Salmon M.et al.Inhibition of fibrocyte differentiation by serum amyloid P[J].J.Immunol,2003,171 (10):5537-5546.
  • 5Hawkins P N,Tennent G A,Woo P,et al.Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amy-loidosis[J].Clin Exp Immunol,1991,84(2):308-316.
  • 6Pilling D,Roife D,Wang M,et al.Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P[J]J Immunol,2007,179(6):4035 -4044.
  • 7Haudek SB,Trial J,Xia Y,et al.Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells[J].Proc Natl.Acad Sci U SA,2008,105(29):10179-10184.
  • 8He T C,Zhou S,da Costa L T,et al.A simplified system for generating recombinant adenoviruses[J].Proc Natl Acad Sci U S A,1998,95(5):2509-2514.
  • 9Rosenfeld M A,Siegfried W,Yoshimura K,et al.Adenovirus-tnedi-ated transfer of a recombinant alpha disease[J].Int J Biochem Cell Biol,2009,41(8-9):1643-1651.

同被引文献18

  • 1Yu J,Chu E H,Wang R,et al.Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice[J].Gastroenterology,2010,138(2):694-704.
  • 2Hayashi S,Leu D,Yamii Y,et al.Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation[J].Transplantation,2005,80 (4):494-499.
  • 3Wilson D S,Nock S.Recent developments in protein microarray technology[J].Angew Chem Int Ed Engl,2003,42(5):494-500.
  • 4Kinoshita K,Iimuro Y,Fujimoto J,et al.Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis[J].Gut,2007,56(3):396-404.
  • 5Bueno M,Salgado S,Beas-Zárate C,et al.Urokinase-type plasminogen activator gene therapy in liver cirrhosis ismediated by collagens gene expression down-u-lation and up-regulation of MMPs,HGF and VEGF[J].J GeneMed,2006,8(11):1291-1299.
  • 6Lin Y,Xie W F,Chen Y X,et al.Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes[J].Liver Int,2005,25 (4):796-807.
  • 7Gerrard L,Zhao D,Clark A J,et al.Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency[J].Stem Cells,2005,23(1):124-133.
  • 8Bach F H.Heme oxygenase-1:a therapeutic amplification funnel[J].Faseb J,2005,19(10):1216-1219.
  • 9Zhu Z,Wilson A T,Mathahs M M,et al.Hemeoxygenase-1 supp resses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury[J].Hepa tology,2008,48(5):1430-1439.
  • 10Abraham N G,Kappas A.Pharmacological and clinical aspects of heme oxygen ase[J|.Pharmacol Rev,2008,60 (1):79-127.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部